Piper Jaffray upgraded Achillion Pharmaceuticals (NASDAQ: ACHN) from Neutral to Overweight with a price target of $10.00 (from $5.00). Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE